See what questions
a doctor would ask.
It has already been acknowledged that hormone replacement therapy increases the risk of breast and endometrial cancer, coronary heart disease and stroke. New research has examined the link with ovarian cancer. The results indicated that cumulative oral intake of estrogen was a significant factor in increasing the risk of ovarian cancer. The progesterone component of hormone therapy had no effect on incidence of ovarian cancer. Thus, it is important that estrogen use should be minimized or replaced with progestogen only if possible.
Source: summary of medical news story as reported by Reuters Health - Archives of Internal Medicine
About: Oral estrogen directly increases the risk of ovarian cancer
Date: 25 November 2004
Source: Reuters Health - Archives of Internal Medicine
http:/ This summary article refers to the following medical categories:
Related Medical Topics
More News Topics
This summary article refers to the following medical categories:
Search Specialists by State and City